Red wine-based drug may help curb obesity, diabetes

08/18/2011 | Daily Mail (London), The

A study in Scientific Reports found that mice taking resveratrol-based SRT1720 drugs did not gain extra weight, had improved stamina and were protected from diabetes despite having a high-fat diet. The drug has also extended the life span of mice in the junk food group by up to 44%. The findings suggest that drugs based on resveratrol, commonly found in red wines, may address obesity, diabetes, heart disease and cancer, experts said.

View Full Article in:

Daily Mail (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA